Mintiva

Selexys Pharmaceuticals? pioneering work on the molecular mechanisms of inflammation has led to breakthroughs in novel therapeutics for inflammatory and thrombotic diseases and positioned Selexys with strong scientific underpinnings.

Sensulin LLC is developing a true once-a-day glucose-responsive insulin that may mimic a healthy human pancreas.

Synereca Pharmaceuticals was created to address the growing problem of bacterial resistance to current antibiotics by developing orally active drugs that restore or increase the effectiveness of existing antibiotics.?

Tetherex is focused on development of anti-PSGL-1 antibodies for the treatment of inflammatory and thrombotic diseases.

UltraBotanica developed a method to bind curcumin to whey protein – effectively increasing the bioavailability by more than 15,000 times.